Frontage Laboratories Completes Acquisition of Teddy Clinical Research Laboratory (Shanghai)

March 4, 2026

Frontage Laboratories, Inc. completed its acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. to expand Frontage’s global central laboratory capabilities and strengthen its footprint in China and the Asia-Pacific region. Teddy Lab will be integrated into Frontage’s “one-stop shop” CRO/CDMO service platform to support growing demand for domestic and multi-regional clinical trials.

Buyers
Frontage Laboratories, Inc., Frontage Laboratories (wholly owned subsidiary of Frontage Holdings Corporation)
Targets
Teddy Clinical Research Laboratory (Shanghai), Ltd.
Location
China
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.